T2 Biosystems, Inc. Deferred Tax Assets, Gross
T2 Biosystems, Inc. had Deferred Tax Assets, Gross of $89.36 million as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2024-04-01
- 2023-12-31: Deferred Tax Assets, Gross $89.36M.
- 2022-12-31: Deferred Tax Assets, Gross $90.50M.
- 2021-12-31: Deferred Tax Assets, Gross $87.83M.
- 2020-12-31: Deferred Tax Assets, Gross $75.75M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2023-12-31 | $89.36M 10-K · filed 2024-04-01 | |
| 2022-12-31 | $90.50M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $87.83M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $75.75M 10-K · filed 2022-03-23 | |
| 2019-12-31 | $60.92M 10-K · filed 2021-03-31 | $105.36M 10-K · filed 2020-03-16 |
| 2018-12-31 | $90.53M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $77.66M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $84.18M 10-K · filed 2018-03-19 | |
| 2015-12-31 | $62.08M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $43.18M 10-K · filed 2016-03-09 | |
| 2013-12-31 | $30.15M 10-K · filed 2015-03-04 |